Aimee E. Hammerstrom

Post‐transplantation cyclophosphamide versus conventional graft‐versus‐host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation

E. Shpall, U. Popat, Q. Bashir, 2016, British journal of haematology.

Results of a 2‐arm, phase 2 clinical trial using post‐transplantation cyclophosphamide for the prevention of graft‐versus‐host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation

K. Rezvani, D. Marin, E. Shpall, 2016, Cancer.

Prevention of Cytomegalovirus Reactivation in Haploidentical Stem Cell Transplantation.

R. Champlin, R. Chemaly, S. Pingali, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Characterization of Viral Infections after Antithymocyte Globulin-Based Conditioning in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

D. Milton, B. Oran, E. Ariza-Heredia, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Tacrolimus‐associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation

U. Popat, R. Champlin, G. Rondón, 2013, American journal of hematology.

Cancer Immunotherapy: Sipuleucel‐T and Beyond

P. Sharma, B. Atkinson, D. Cauley, 2011, Pharmacotherapy.

Defining the impact of the use of granulocyte colony stimulating factors on the incidence of chemotherapy-induced neutropenia in patients with gynecologic malignancies

D. Bodurka, Caimiao Wei, Judith A. Smith, 2017, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Possible Amlodipine-Induced Hepatotoxicity After Stem Cell Transplant

Aimee E. Hammerstrom, 2015, The Annals of pharmacotherapy.

Haploidentical transplantation (HaploSCT) with post-transplant cyclophosphamide (PTCy) and melphalan-based conditioning: A retrospective analysis of the first 100 patients treated at MD Anderson Cancer Center.

S. Parmar, E. Shpall, U. Popat, 2014 .

Results of a 2‐arm, phase 2 clinical trial using post‐transplantation cyclophosphamide for the prevention of graft‐versus‐host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation

K. Rezvani, D. Marin, E. Shpall, 2016, Cancer.